Quick Dispatch:
Your surmount-osa trial tirzepatide results Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your surmount-osa trial tirzepatide results Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial ships.
Need Help?
Questions about surmount-osa trial tirzepatide results Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for surmount-osa trial tirzepatide results Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial in your area.
SURMOUNT-5 (NCT05822830) top line results announced. Adults w/ obesity + at least one of the following obesity-related diseases: htn, dyslipidemia, obstructive sleep apnea (OSA) or cvd, w/o dm Tirzepatide weight loss of
20.13
SURMOUNT-OSA Results: 'Impressive' in Improving Sleep Apnea
21.51
Full article: What impact could tirzepatide have on major cardiovascular complications in patients with obstructive sleep apnea?
24.56
Tirzepatide Shows Benefit in Obstructive Sleep Apnea, SURMOUNT-OSA Trial
27.60
Tirzepatide for sleep-disordered breathing in SURMOUNT-OSA: Time course and association with body weight
28.26
SURMOUNT-OSA Shows Tirzepatide is Effective for Treating Sleep Apnea
22.94
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity 🔗 @NEJM 🔗 https://t.co/RKdvTJxd7Y #ADA2024
27.41
